Cargando…

Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease

The discovery of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system has revolutionized gene editing research. Through the repurposing of programmable RNA-guided CRISPR-associated (Cas) nucleases, CRISPR-based genome editing systems allow for the precise modification of spe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baker, Catherine, Hayden, Matthew S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265575/ https://www.ncbi.nlm.nih.gov/pubmed/32528662 http://dx.doi.org/10.12688/f1000research.23185.2

Ejemplares similares

Harnessing CRISPR-Cas system diversity for gene editing technologies
por: McKay, Alexander, et al.
Publicado: (2021)

Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease
por: Limanskiy, Viktor, et al.
Publicado: (2019)

Harnessing Type I and Type III CRISPR-Cas systems for genome editing
por: Li, Yingjun, et al.
Publicado: (2016)

Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics
por: Liu, Wenyi, et al.
Publicado: (2021)

Advanced domestication: harnessing the precision of gene editing in crop breeding
por: Lyzenga, Wendy J., et al.
Publicado: (2021)

Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium
por: Pyne, Michael E., et al.
Publicado: (2016)

Harnessing CRISPR-Cas9 for Genome Editing in Streptococcus pneumoniae D39V
por: Synefiaridou, Dimitra, et al.
Publicado: (2021)

CRISPR-Cas9 gene editing and human diseases
por: Jinka, Chaitra, et al.
Publicado: (2022)

Harnessing the Potential of CRISPR/Cas in Atherosclerosis: Disease Modeling and Therapeutic Applications
por: Siew, Wei Sheng, et al.
Publicado: (2021)

Resources for the design of CRISPR gene editing experiments
por: Graham, Daniel B., et al.
Publicado: (2015)

The Potential of CRISPR-Guided Therapies in the Dermatology Clinic
por: Bhat, Prashant, et al.
Publicado: (2022)

Cutaneous Signs in Dermatological Diseases; An Overview
por: Sharma, Surabhi, et al.
Publicado: (2021)

CRISPR to the Rescue: Advances in Gene Editing for the FMR1 Gene
por: Yrigollen, Carolyn M., et al.
Publicado: (2019)

CRISPR: a journey of gene-editing based medicine
por: Golkar, Zhabiz
Publicado: (2020)

Applications of the CRISPR/Cas system beyond gene editing
por: Anton, Tobias, et al.
Publicado: (2018)

Challenges of CRISPR-Based Gene Editing in Primary T Cells
por: Rezalotfi, Alaleh, et al.
Publicado: (2022)

CRISPR as a strong gene editing tool
por: Shen, Shengfu, et al.
Publicado: (2017)

Application of CRISPR-Cas9 gene editing for congenital heart disease
por: Seok, Heeyoung, et al.
Publicado: (2021)

Harnessing the immune system in the treatment of cutaneous T cell lymphomas
por: Fay, Christopher J., et al.
Publicado: (2023)

Interrogating Mitochondrial Biology and Disease Using CRISPR/Cas9 Gene Editing
por: Tang, Jia-Xin, et al.
Publicado: (2021)

Control of Bacterial Diseases of Banana Using CRISPR/Cas-Based Gene Editing
por: Tripathi, Leena, et al.
Publicado: (2022)

CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics
por: Bhardwaj, Shanu, et al.
Publicado: (2021)

CRISPR-Mediated Epigenome Editing
por: Enríquez, Paul
Publicado: (2016)

Monoclonal Antibodies, Gene Silencing and Gene Editing (CRISPR) Therapies for the Treatment of Hyperlipidemia—The Future Is Here
por: Hermel, Melody, et al.
Publicado: (2023)

Harnessing the Potential of Human Pluripotent Stem Cells and Gene Editing for the Treatment of Retinal Degeneration
por: Ovando-Roche, Patrick, et al.
Publicado: (2017)

Multiplexed CRISPR technologies for gene editing and transcriptional regulation
por: McCarty, Nicholas S., et al.
Publicado: (2020)

Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)

CRISPR Gene Editing in Lipid Disorders and Atherosclerosis: Mechanisms and Opportunities
por: Walker, Harry E., et al.
Publicado: (2021)

CRISPR/Cas9-gene editing approaches in plant breeding
por: Saini, Himanshu, et al.
Publicado: (2023)

Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics
por: Chan, Kok Gan, et al.
Publicado: (2021)

Harnessing Genome Editing Techniques to Engineer Disease Resistance in Plants
por: Mushtaq, Muntazir, et al.
Publicado: (2019)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
por: Rahman, Mujeeb ur, et al.
Publicado: (2022)

Toward the Treatment of Inherited Diseases of the Retina Using CRISPR-Based Gene Editing
por: Hernández-Juárez, Jennifer, et al.
Publicado: (2021)

Harnessing the Power of Induced Pluripotent Stem Cells and Gene Editing Technology: Therapeutic Implications in Hematological Malignancies
por: Sidhu, Ishnoor, et al.
Publicado: (2021)

Shining Light on CRISPR Gene Editing
por: Taemaitree, Lapatrada, et al.
Publicado: (2020)

Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR/Cas9-mediated genome editing
por: Guo, Tao, et al.
Publicado: (2018)

Role of Cutaneous Microbiome in Dermatology
por: Mustari, Akash P., et al.
Publicado: (2023)

Plant genome editing with TALEN and CRISPR
por: Malzahn, Aimee, et al.
Publicado: (2017)

Selecting for CRISPR-Edited Knock-In Cells
por: Reuven, Nina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6ls1egm2unq329uf7k2kinjpct